featured
Oral Paclitaxel Plus Encequidar vs Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
J. Clin. Oncol 2022 Jul 20;[EPub Ahead of Print], HS Rugo, GA Umanzor, FJ Barrios, RH Vasallo, MA Chivalan, S Bejarano, JR Ramírez, L Fein, RD Kowalyszyn, ED Kramer, H Wang, MR Kwan, DL CutlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.